E-mail a Friend

Clinical Trials Offered at UMBTI

Clinical research provides the necessary information researchers use to design better treatments for brain tumors. All of our current therapies have evolved through the clinical trial process and by choosing to participate in a clinical trial, you are helping researchers find better treatments for others.

A clinical trial may also help you by:
  • Receiving an experimental drug or new brain tumor treatment not available outside a clinical trial
  • Benefiting from a team of health professionals who follow a carefully designed protocol based on the latest known evidence about cancer care
  • Knowing they are helping other people suffering from brain cancer

Macarena de la Fuente, MD

UMBTI Neuro-oncologist

At the UMBTI, we offer the following trials for our brain tumor patients:

For newly diagnosed glioblastoma:

Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma
Investigator: Macarena de la Fuente, MD
ClinicalTrials.gov Identifier:NCT02667587

Study of Nivolumab Compared to Temozolomide, Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma
Investigator: Macarena de la Fuente, MD
ClinicalTrials.gov Identifier:NCT02617589

For recurrent gliomas:

Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma
Investigator: Macarena de la Fuente, MD
ClinicalTrials.gov Identifier:NCT01808820

BGJ398 for Patients With Tumors With FGFR Genetic Alterations
Investigator: Macarena de la Fuente, MD
ClinicalTrials.gov Identifier:NCT02160041

Molecular Analysis for Therapy Choice (MATCH)
Investigator: Brian Slomovitz, MD
ClinicalTrials.gov Identifier:NCT02465060
For recurrent meningiomas:

A Study Looking at Targeted Therapy According to Tumor Markers for People With Meningiomas
Investigator: Macarena de la Fuente, MD
ClinicalTrials.gov Identifier:NCT02523014

For solid tumors:

An Open Label, Phase 2 Study of Neratinib in Patients with Solid Tumors with Somatic Human Epidermal Growth Factor Receptor (EGFR, HER2, HER3) Mutations or EGFR Gene Amplification
Investigator: Macarena de la Fuente, MD
ClinicalTrials.gov Identifier:NCT01953926

Questions regarding our trials?

Heleven Delgado, RN, MSN
UMBTI Nurse Navigator
Office: 305.243.4235
Fax: 305.243.5303
Email: HDelgado@med.miami.edu

logo

For a detailed list of all the trials offered at Sylvester:
Sylvester List for Brain and Nervous System Trials

E-mail a Friend